{
  "docId": "019de076-7746-74ba-85f9-63c229edc49f",
  "docSlug": "987f138dade45ff64effcbdaa91cb6f6",
  "documentTitle": "Absci | Investor Presentation Deck | 42 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 35,
  "pageCount": 42,
  "prevPage": 34,
  "nextPage": 36,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-7746-74ba-85f9-63c229edc49f/35",
  "deckHref": "/decks/019de076-7746-74ba-85f9-63c229edc49f",
  "deckJsonHref": "/decks/019de076-7746-74ba-85f9-63c229edc49f.json",
  "deckAnchorHref": "/decks/019de076-7746-74ba-85f9-63c229edc49f#slide-35",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "image",
      "text": "Icons representing GPCRs, antibodies, optimization, and IP defense",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b3003ae-af25-40f3-9a88-603f1d799f58",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.22,
        "x": 0.74,
        "y": 0.25
      },
      "kind": "list",
      "text": "EXPANDED INTELLECTUAL PROPERTY SPACE: AI-drug creation generates broader IP for “first-in-class” and finds new IP for fast follower / “best-in-class”",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa2d25f0-51ba-4c15-a710-261b2ad805bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.22,
        "x": 0.28,
        "y": 0.25
      },
      "kind": "list",
      "text": "SUPERIOR DRUG ATTRIBUTES: Multi-valent biologics, increased half-life, conditional pH dependent binding",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b9673be4-1dee-45db-8f97-4bbd76d5291a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.22,
        "x": 0.51,
        "y": 0.25
      },
      "kind": "list",
      "text": "INCREASED SUCCESS RATE: Multi-parametric optimization creates higher quality biologics",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8f7b77e-5f9e-4fae-abbe-be9f2b4d2ad8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.22,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "list",
      "text": "ACCESS TO NOVEL DISEASE BIOLOGY: Ability to address elusive drug targets, e.g. GPCRs, ion channels",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbe07700-1f9e-4e84-ab0f-b30fe6250d2f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Potential to enable our partners with",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0128d375-093c-46fb-a064-ce8bff02600d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "6e4efaf8-23f0-48aa-af61-61bf46c61720",
      "evidence": "The slide presents a list of benefits (EXPANDED INTELLECTUAL PROPERTY SPACE, SUPERIOR DRUG ATTRIBUTES, etc.) in a clear and concise manner.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 36,
      "from": 34,
      "beatId": "1510d50c-089f-4f30-897a-67ad1254ebb2",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Go-to-market",
      "beatSlug": null,
      "evidence": "Pages 34-36 discuss ways to work together and industry-leading collaborations",
      "position": 8,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}